Palantir Technologies Inc. (NYSE:PLTR) shares are trading higher premarket Tuesday. The company inked a multi-year, multi-million-dollar contract with Nebraska Medicine. As per the deal, Palantir will utilize its Artificial Intelligence Platform (AIP) to enhance healthcare through transformative technologies. Palantir and Nebraska Medicine began their collaboration in January 2024, with a shared mission to quickly address critical healthcare challenges. Palantir plans to continue its partnership
Recent market activity has seen U.S. stocks rebound significantly, with growth stocks, particularly in the technology sector, outpacing value shares. This resurgence is driven by positive sentiment from key investment conferences and strong performances from tech giants like NVIDIA. In light of these developments, identifying high-growth tech stocks that can potentially offer robust returns involves looking for companies with strong fundamentals and innovative capabilities that align well...
After listening to the enterprise AI specialist's latest earnings call, I have some concerns over where the company is headed.